Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
The 2014-2016 Ebola outbreak in West Africa was the largest in history leading to 28,639 cases, of which 40% were fatal. Better treatments and effective vaccines against Ebola virus are needed to prevent future recurrence. Multiple, novel, treatment options were assessed during the outbreak, includi...
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Conference item |
| Baskı/Yayın Bilgisi: |
Elsevier
2017
|